157 related articles for article (PubMed ID: 20001863)
1. CHF1/Hey2 promotes physiological hypertrophy in response to pressure overload through selective repression and activation of specific transcriptional pathways.
Yu M; Liu Y; Xiang F; Li Y; Cullen D; Liao R; Beyer RP; Bammler TK; Chin MT
OMICS; 2009 Dec; 13(6):501-11. PubMed ID: 20001863
[TBL] [Abstract][Full Text] [Related]
2. The bHLH transcription factor CHF1/Hey2 regulates susceptibility to apoptosis and heart failure after pressure overload.
Liu Y; Yu M; Wu L; Chin MT
Am J Physiol Heart Circ Physiol; 2010 Jun; 298(6):H2082-92. PubMed ID: 20382855
[TBL] [Abstract][Full Text] [Related]
3. Transcription factor CHF1/Hey2 suppresses cardiac hypertrophy through an inhibitory interaction with GATA4.
Xiang F; Sakata Y; Cui L; Youngblood JM; Nakagami H; Liao JK; Liao R; Chin MT
Am J Physiol Heart Circ Physiol; 2006 May; 290(5):H1997-2006. PubMed ID: 16603706
[TBL] [Abstract][Full Text] [Related]
4. Myocardial deletion of transcription factor CHF1/Hey2 results in altered myocyte action potential and mild conduction system expansion but does not alter conduction system function or promote spontaneous arrhythmias.
Hartman ME; Liu Y; Zhu WZ; Chien WM; Weldy CS; Fishman GI; Laflamme MA; Chin MT
FASEB J; 2014 Jul; 28(7):3007-15. PubMed ID: 24687990
[TBL] [Abstract][Full Text] [Related]
5. Transcription factor CHF1/Hey2 regulates coronary vascular maturation.
Watanabe T; Koibuchi N; Chin MT
Mech Dev; 2010; 127(9-12):418-27. PubMed ID: 20619341
[TBL] [Abstract][Full Text] [Related]
6. Transcription Factor CHF1/Hey2 Regulates Specific Pathways in Serum Stimulated Primary Cardiac Myocytes: Implications for Cardiac Hypertrophy.
Yu M; Xiang F; Beyer RP; Farin FM; Bammler TK; Chin MT
Curr Genomics; 2010 Jun; 11(4):287-96. PubMed ID: 21119893
[TBL] [Abstract][Full Text] [Related]
7. Transcription factor CHF1/Hey2 regulates EC coupling and heart failure in mice through regulation of FKBP12.6.
Liu Y; Korte FS; Moussavi-Harami F; Yu M; Razumova M; Regnier M; Chin MT
Am J Physiol Heart Circ Physiol; 2012 May; 302(9):H1860-70. PubMed ID: 22408025
[TBL] [Abstract][Full Text] [Related]
8. Regulation of MMP10 expression by the transcription factor CHF1/Hey2 is mediated by multiple E boxes.
Wu L; Chien WM; Hartman ME; Moussavi-Harami F; Liu Y; Chin MT
Biochem Biophys Res Commun; 2011 Dec; 415(4):662-8. PubMed ID: 22079635
[TBL] [Abstract][Full Text] [Related]
9. CHF1/Hey2 plays a pivotal role in left ventricular maturation through suppression of ectopic atrial gene expression.
Koibuchi N; Chin MT
Circ Res; 2007 Mar; 100(6):850-5. PubMed ID: 17332425
[TBL] [Abstract][Full Text] [Related]
10. CHF1/Hey2 suppresses SM-MHC promoter activity through an interaction with GATA-6.
Shirvani S; Xiang F; Koibuchi N; Chin MT
Biochem Biophys Res Commun; 2006 Jan; 339(1):151-6. PubMed ID: 16293227
[TBL] [Abstract][Full Text] [Related]
11. The spectrum of cardiovascular anomalies in CHF1/Hey2 deficient mice reveals roles in endocardial cushion, myocardial and vascular maturation.
Sakata Y; Koibuchi N; Xiang F; Youngblood JM; Kamei CN; Chin MT
J Mol Cell Cardiol; 2006 Feb; 40(2):267-73. PubMed ID: 16242143
[TBL] [Abstract][Full Text] [Related]
12. Postnatal ablation of Foxm1 from cardiomyocytes causes late onset cardiac hypertrophy and fibrosis without exacerbating pressure overload-induced cardiac remodeling.
Bolte C; Zhang Y; York A; Kalin TV; Schultz Jel J; Molkentin JD; Kalinichenko VV
PLoS One; 2012; 7(11):e48713. PubMed ID: 23144938
[TBL] [Abstract][Full Text] [Related]
13. Transcription factor CHF1/Hey2 regulates the global transcriptional response to platelet-derived growth factor in vascular smooth muscle cells.
Shirvani SM; Mookanamparambil L; Ramoni MF; Chin MT
Physiol Genomics; 2007 Jun; 30(1):61-8. PubMed ID: 17327490
[TBL] [Abstract][Full Text] [Related]
14. NULP1 Alleviates Cardiac Hypertrophy by Suppressing NFAT3 Transcriptional Activity.
Zhang X; Lei F; Wang XM; Deng KQ; Ji YX; Zhang Y; Li H; Zhang XD; Lu Z; Zhang P
J Am Heart Assoc; 2020 Aug; 9(16):e016419. PubMed ID: 32805187
[TBL] [Abstract][Full Text] [Related]
15. Partial inhibition of activin receptor-like kinase 4 attenuates pressure overload-induced cardiac fibrosis and improves cardiac function.
Li CY; Chen YH; Wang Q; Hou JW; Wang H; Wang YP; Li YG
J Hypertens; 2016 Sep; 34(9):1766-77. PubMed ID: 27379535
[TBL] [Abstract][Full Text] [Related]
16. Hey basic helix-loop-helix transcription factors are repressors of GATA4 and GATA6 and restrict expression of the GATA target gene ANF in fetal hearts.
Fischer A; Klattig J; Kneitz B; Diez H; Maier M; Holtmann B; Englert C; Gessler M
Mol Cell Biol; 2005 Oct; 25(20):8960-70. PubMed ID: 16199874
[TBL] [Abstract][Full Text] [Related]
17. Targeted disruption of Hspa4 gene leads to cardiac hypertrophy and fibrosis.
Mohamed BA; Barakat AZ; Zimmermann WH; Bittner RE; Mühlfeld C; Hünlich M; Engel W; Maier LS; Adham IM
J Mol Cell Cardiol; 2012 Oct; 53(4):459-68. PubMed ID: 22884543
[TBL] [Abstract][Full Text] [Related]
18. Growth Arrest-Specific 6 Exacerbates Pressure Overload-Induced Cardiac Hypertrophy.
Zhao YF; Xu DC; Zhu GF; Zhu MY; Tang K; Li WM; Xu YW
Hypertension; 2016 Jan; 67(1):118-29. PubMed ID: 26573712
[TBL] [Abstract][Full Text] [Related]
19. Chronic Pressure Overload Induces Cardiac Hypertrophy and Fibrosis via Increases in SGLT1 and IL-18 Gene Expression in Mice.
Matsushita N; Ishida N; Ibi M; Saito M; Sanbe A; Shimojo H; Suzuki S; Koepsell H; Takeishi Y; Morino Y; Taira E; Sawa Y; Hirose M
Int Heart J; 2018 Sep; 59(5):1123-1133. PubMed ID: 30101852
[TBL] [Abstract][Full Text] [Related]
20. The valosin-containing protein is a novel repressor of cardiomyocyte hypertrophy induced by pressure overload.
Zhou N; Ma B; Stoll S; Hays TT; Qiu H
Aging Cell; 2017 Oct; 16(5):1168-1179. PubMed ID: 28799247
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
